Table 3.

Clinical characteristics of SARS-CoV-2 vaccinees.

Donor	HLA-A2	Sex	Age	BMI	Time*	Symptoms
code	restriction			(kg/m2)	(days)
# 1	Yes	Female	23	20.84	118	NO
# 2	Yes	Male	37	19.42	116	NO
# 3	Yes	Female	43	21.52	118	NO
# 4	Yes	Male	52	24.34	118	Local redness and swelling
# 5	Yes	Female	45	24.32	118	NO
# 6	Yes	Male	46	21.28	118	NO
# 7	Yes	Male	29	21.63	118	NO
# 8	Yes	Female	49	21.63	116	Dizziness for
						4 h
# 9	Yes	Male	23	21.34	116	NO
# 10	Yes	Female	25	22.29	118	NO
# 11	Yes	Male	34	23.43	118	NO
# 12	Yes	Male	23	21.82	116	NO
# 13	Yes	Female	38	21.43	115	NO
#14	Yes	Male	41	23.31	118	NO
# 15	Yes	Female	53	23.14	118	NO
# 16	Yes	Male	23	19..24	116	NO
# 17	Yes	Female	40	22.35	116	NO

^*The time interval between the second injection vaccination and blood sampling.